Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Single-Cell Dissection of Human Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

    Hematopoietic stem cell transplantation (HSCT) is a regenerative therapy used to treat various malignant, inherited, or autoimmune diseases. Despite its success, the understanding of hematopoietic reconstitution in transplant patients remains…

    2024.01.22
  • The Complexity of Diffuse Large B-Cell Lymphoma: A Revolutionary Genetic Subtyping Algorithm

    Diffuse large B-cell lymphoma (DLBCL), the most prevalent subtype of non-Hodgkin’s lymphoma, presents a significant challenge in its treatment due to its molecular heterogeneity. Despite advancements in immunochemotherapy, a substantial…

    2024.01.22
  • The Role of PD-1 Signaling in T-Cell Acute Lymphoblastic Leukemia: A Revolutionary Breakthrough

    T-cell acute lymphoblastic leukemia (T-ALL) emerges as a formidable adversary within the spectrum of blood cancers, marked by the rapid proliferation of immature T-cell progenitors. The imperative to unravel the…

    2024.01.22
  • Multi-Omics Blood Atlas Reveals Unique Features of Immune and Platelet Responses to SARS-CoV-2 Omicron Breakthrough Infection

    The COVID-19 pandemic caused by SARS-CoV-2 has affected millions of people worldwide. The emergence of new variants, such as Omicron, has raised concerns about the effectiveness of immune responses and…

    2024.01.22
  • Advancing Precision Medicine in Diffuse Large B Cell Lymphoma: Insights from the GUIDANCE-01 Trial

    Diffuse large B cell lymphoma (DLBCL) stands as the most prevalent subtype among non-Hodgkin lymphomas, presenting unique challenges in its treatment due to its genetic heterogeneity.The GUIDANCE-01 trial, designed as…

    2024.01.22
  • Excessive Serine Impairs Megakaryopoiesis and Thrombopoiesis in Multiple Myeloma

    Thrombocytopenia, a major complication in multiple myeloma (MM) patients, is associated with poor prognosis. However, the factors contributing to thrombocytopenia in MM and their significance are not well understood. Recent…

    2024.01.22
  • Ex utero Monkey Embryogenesis: Advancements in In vitro Culture System”

    This is groundbreaking research. Researchers have developed an embedded three-dimensional (3D) culture system for monkey embryos, enabling in vitro culturing up to 25 days post-fertilization, overcoming previous limitations. The Enhanced Monkey Ex Utero…

    2024.01.22
  • Anti-GPRC5D CAR-TCell Therapy: A Breakthrough for Multiple Myeloma

    Multiple myeloma (MM) is a challenging hematologic cancer characterized by uncontrollable plasma cell proliferation in the bone marrow. Despite advancements in MM treatments, relapse or refractory cases are common. Chimeric…

    2024.01.22
«previous next»
Recent Posts
  • 2026 Pujiang Urological Oncology Academic Conference丨Professor Hailiang Zhang: From Mechanisms of Immunotherapy Resistance to Precision Risk Stratification and Treatment—New Insights from the “Eggshell Structure” Discovered Through Spatial Multi-Omics and Advances in Systemic Therapy for Urological Tumors
  • CACA GU丨Professor Gang Zhu: Integrating the Full-Course Management of Urological Cancers—from Strengthening Prevention and Screening to Multidisciplinary Collaboration
  • CACA GU丨Yuanxin Jia: Advancing Comprehensive Urologic Oncology Management Through Precision, Risk Stratification, and Individualized Care
  • 2026 Pujiang Urological Oncology Academic Conference丨Chunguang Ma: Immunotherapy Opens a New Era in Adjuvant Treatment for Urothelial Carcinoma—From a Shift in Perioperative Concepts to Precision Whole-Course Management
  • Professor Yongmei Yin: Advancing Precision Oncology from Concept to Clinical Practice — Key Insights from the 2026 “Renyi” Clinical Research Conference on Innovative Anticancer Drugs
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top